Skip to main content
. 2014 Sep 29;60(2):119–129. doi: 10.1007/s12223-014-0349-8

Table 2.

Susceptibility of selected isolates tested in Mueller-Hinton broth (strains with same behavior were excluded; the data are presented in Fig. 1)

Isolate Species β-Lactamase MIC WO MIC, BIC [mg/L]
Ceftazidime Cefepime Ertapenem Meropenem Imipenem Doripenem
ATCC25922 E. coli 0.125 0.125 0.064 0.032 0.016 0.032 0.016 0.016 0.125 0.064 0.016 0.016
OXA-48-type producers
 OXA_N1 Citrobacter freundii OXA-162, SHV-5 >32 2 4 ≤0.5 4 >32 0.5 4 0.5 ≤0.5 ≤0.5 2
 OXA_N2 Enterobacter cloacae OXA-48, TEM-1, CTX-M-15 >32 8 32 4 >32 >32 32 >32 16 8 16 16
 OXA_N3 E. coli OXA-162, TEM-1 0.5 ≤0.5 1 ≤0.5 >32 >32 16 >32 4 2 8 16
 OXA_N4 E. coli OXA-48, TEM-1, OXA-1 4 1 16 4 >32 >32 32 >32 32 8 16 1
 OXA_N5 E. coli OXA-48, TEM-1, OXA-1 32 4 32 2 4 >32 0.5 8 0.5 ≤0.5 ≤0.5 1
 OXA_N6 E. coli OXA-48, TEM-1, OXA-1 0.5 ≤0.5 0.5 ≤0.5 0.5 32 ≤0.5 2 ≤0.5 ≤0.5 ≤0.5 ≤0.5
 OXA_C3 K. pneumoniae OXA-48, SHV-1 4 4 16 1 1 >32 ≤0.5 8 ≤0.5 ≤0.5 ≤0.5 1
 OXA_N9 Raoultela ornithinolytica OXA-162, TEM-1, OXA-1, SHV-5 >32 1 2 ≤0.5 4 >32 0.5 4 0.5 ≤0.5 ≤0.5 4
Other carbapenemase-producing isolates
 KPC_C1 K. pneumoniae KPC-2, OXA-9, TEM-1, SHV-12 >32 >32 16 16 >32 >32 8 >32 8 2 4 2
 KPC_C2 K. pneumoniae KPC-3, OXA-9, TEM-1, SHV-12 >32 >32 >32 16 >32 >32 >32 >32 8 1 32 32
 KPC_C3 K. pneumoniae KPC-3, OXA-9, TEM-1, SHV-12 8 16 8 1 1 >32 ≤0.5 8 ≤0.5 ≤0.5 ≤0.5 8
 NDM_B1 E. coli NDM-1, TEM-1 >32 16 >32 4 16 16 4 4 2 0.5 8 32
 NDM_B2 Citrobacter freundii NDM-1, TEM-1, intrinsic AmpC 32 32 16 8 >32 >32 8 >32 4 2 16 2
 NDM_B3 Providencia stuartii NDM-1, intrinsic AmpC >32 >32 8 8 4 16 4 16 8 16 4 2
 VIM_C1 K. pneumoniae VIM-1, SHV-1 >32 >32 >32 8 >32 >32 >32 >32 16 1 >32 >32
 VIM_C2 K. pneumoniae VIM-1, SHV-1 >32 16 >32 8 4 >32 1 8 1 ≤0.5 2 2
 VIM_C3 K. pneumoniae VIM-1, SHV-1 >32 >32 32 32 4 >32 4 32 2 2 4 16
 VIM_C4 K. pneumoniae VIM-4, CMY-4 >32 >32 >32 16 >32 >32 >32 32 8 2 >32 8
Non-carbapenemase-producing carbapenem resistant isolates
 DHA_C1 K. pneumoniae DHA-1, TEM-1, OXA-1 >32 32 >32 16 >32 >32 2 32 2 8 2 4
 DHA_C2 K. pneumoniae DHA-1, TEM-1, OXA-1, SHV-5 >32 >32 >32 8 >32 >32 8 16 4 4 4 1
 DHA_C3 K. pneumoniae DHA-1, TEM-1, OXA-1 >32 >32 2 2 >32 16 4 4 1 ≤0.5 2 0.5
 SHV_C1 K. pneumoniae TEM-1, SHV-1, SHV-5 >32 8 >32 16 >32 32 4 4 1 ≤0.5 2 ≤0.5
 SHV_C2 K. pneumoniae TEM-1, SHV-1, SHV-5 >32 4 >32 16 8 >32 2 4 2 1 1 0.5
Carbapenem susceptible isolates
 ESBL_P1 E. coli TEM-1, OXA-1, CTX-M-15 32 2 16 1 ≤0.5 16 ≤0.5 ≤0.5 ≤0.5 ≤0.5 ≤0.5 ≤0.5
 ESBL_P2 K. pneumoniae TEM-1, SHV-1, SHV-5 32 16 4 ≤0.5 ≤0.5 2 ≤0.5 ≤0.5 ≤0.5 ≤0.5 ≤0.5 ≤0.5
 ESBL_P3 K. pneumoniae TEM-1, SHV-1, SHV-5 >32 8 2 ≤0.5 ≤0.5 4 ≤0.5 ≤0.5 ≤0.5 ≤0.5 ≤0.5 ≤0.5
 ESBL_P4 K. pneumoniae TEM-1, SHV-1, SHV-12 >32 16 2 ≤0.5 ≤0.5 2 ≤0.5 ≤0.5 ≤0.5 ≤0.5 ≤0.5 ≤0.5
 ESBL_P5 Providencia stuartii TEM-92, intrinsic AmpC 16 ND 8 ND ≤0.5 ND ≤0.5 ND ≤0.5 ND ≤0.5 ND

MIC minimal inhibitory concentration, MIC, WO minimal inhibitory concentration determined without NaHCO3, MIC, BIC MIC determined in presence of 50 mmol/L NaHCO3, ND no growth observed

Significant changes are in bold